353 related articles for article (PubMed ID: 32086528)
41. Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks.
Mallm JP; Iskar M; Ishaque N; Klett LC; Kugler SJ; Muino JM; Teif VB; Poos AM; Großmann S; Erdel F; Tavernari D; Koser SD; Schumacher S; Brors B; König R; Remondini D; Vingron M; Stilgenbauer S; Lichter P; Zapatka M; Mertens D; Rippe K
Mol Syst Biol; 2019 May; 15(5):e8339. PubMed ID: 31118277
[TBL] [Abstract][Full Text] [Related]
42. GATA-1-dependent histone H3K27 acetylation mediates erythroid cell-specific chromatin interaction between CTCF sites.
Kim YW; Kang Y; Kang J; Kim A
FASEB J; 2020 Nov; 34(11):14736-14749. PubMed ID: 32924169
[TBL] [Abstract][Full Text] [Related]
43. Disruption of a -35 kb Enhancer Impairs CTCF Binding and
Liu Q; Thoms JAI; Nunez AC; Huang Y; Knezevic K; Packham D; Poulos RC; Williams R; Beck D; Hawkins NJ; Ward RL; Wong JWH; Hesson LB; Sloane MA; Pimanda JE
Clin Cancer Res; 2018 Sep; 24(18):4602-4611. PubMed ID: 29898989
[No Abstract] [Full Text] [Related]
44. Promoter-proximal CTCF binding promotes distal enhancer-dependent gene activation.
Kubo N; Ishii H; Xiong X; Bianco S; Meitinger F; Hu R; Hocker JD; Conte M; Gorkin D; Yu M; Li B; Dixon JR; Hu M; Nicodemi M; Zhao H; Ren B
Nat Struct Mol Biol; 2021 Feb; 28(2):152-161. PubMed ID: 33398174
[TBL] [Abstract][Full Text] [Related]
45. A CTCF-binding site in the Mdm1-Il22-Ifng locus shapes cytokine expression profiles and plays a critical role in early Th1 cell fate specification.
Liu C; Nagashima H; Fernando N; Bass V; Gopalakrishnan J; Signorella S; Montgomery W; Lim AI; Harrison O; Reich L; Yao C; Sun HW; Brooks SR; Jiang K; Nagarajan V; Zhao Y; Jung S; Phillips R; Mikami Y; Lareau CA; Kanno Y; Jankovic D; Aryee MJ; Pękowska A; Belkaid Y; O'Shea J; Shih HY
Immunity; 2024 May; 57(5):1005-1018.e7. PubMed ID: 38697116
[TBL] [Abstract][Full Text] [Related]
46. Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system.
Bornschein S; Demeyer S; Stirparo R; Gielen O; Vicente C; Geerdens E; Ghesquière B; Aerts S; Cools J; de Bock CE
Leukemia; 2018 Apr; 32(4):941-951. PubMed ID: 29151585
[TBL] [Abstract][Full Text] [Related]
47. Variable Extent of Lineage-Specificity and Developmental Stage-Specificity of Cohesin and CCCTC-Binding Factor Binding Within the Immunoglobulin and T Cell Receptor Loci.
Loguercio S; Barajas-Mora EM; Shih HY; Krangel MS; Feeney AJ
Front Immunol; 2018; 9():425. PubMed ID: 29593713
[TBL] [Abstract][Full Text] [Related]
48. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells.
Cardoso BA; de Almeida SF; Laranjeira AB; Carmo-Fonseca M; Yunes JA; Coffer PJ; Barata JT
Leukemia; 2011 Oct; 25(10):1578-86. PubMed ID: 21647153
[TBL] [Abstract][Full Text] [Related]
49. Enhancer release and retargeting activates disease-susceptibility genes.
Oh S; Shao J; Mitra J; Xiong F; D'Antonio M; Wang R; Garcia-Bassets I; Ma Q; Zhu X; Lee JH; Nair SJ; Yang F; Ohgi K; Frazer KA; Zhang ZD; Li W; Rosenfeld MG
Nature; 2021 Jul; 595(7869):735-740. PubMed ID: 34040254
[TBL] [Abstract][Full Text] [Related]
50. Sequential in
Amândio AR; Beccari L; Lopez-Delisle L; Mascrez B; Zakany J; Gitto S; Duboule D
Genes Dev; 2021 Nov; 35(21-22):1490-1509. PubMed ID: 34711654
[TBL] [Abstract][Full Text] [Related]
51. CTCF and CTCFL in cancer.
Debaugny RE; Skok JA
Curr Opin Genet Dev; 2020 Apr; 61():44-52. PubMed ID: 32334335
[TBL] [Abstract][Full Text] [Related]
52. A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation.
Korkmaz G; Manber Z; Lopes R; Prekovic S; Schuurman K; Kim Y; Teunissen H; Flach K; Wit E; Galli GG; Zwart W; Elkon R; Agami R
Nucleic Acids Res; 2019 Oct; 47(18):9557-9572. PubMed ID: 31372638
[TBL] [Abstract][Full Text] [Related]
53. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
Eldholm V; Haugen A; Zienolddiny S
Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
[TBL] [Abstract][Full Text] [Related]
54. Dissection of a CTCF topological boundary uncovers principles of enhancer-oncogene regulation.
Kim KL; Rahme GJ; Goel VY; El Farran CA; Hansen AS; Bernstein BE
Mol Cell; 2024 Apr; 84(7):1365-1376.e7. PubMed ID: 38452764
[TBL] [Abstract][Full Text] [Related]
55. The LDB1 Complex Co-opts CTCF for Erythroid Lineage-Specific Long-Range Enhancer Interactions.
Lee J; Krivega I; Dale RK; Dean A
Cell Rep; 2017 Jun; 19(12):2490-2502. PubMed ID: 28636938
[TBL] [Abstract][Full Text] [Related]
56. Genomic approaches uncover increasing complexities in the regulatory landscape at the human SCL (TAL1) locus.
Dhami P; Bruce AW; Jim JH; Dillon SC; Hall A; Cooper JL; Bonhoure N; Chiang K; Ellis PD; Langford C; Andrews RM; Vetrie D
PLoS One; 2010 Feb; 5(2):e9059. PubMed ID: 20140202
[TBL] [Abstract][Full Text] [Related]
57. Targeting dual oncogenic machineries driven by TAL1 and PI3K-AKT pathways in T-cell acute lymphoblastic leukemia.
Lim FQ; Chan AS; Yokomori R; Huang XZ; Theardy MS; Yeoh AEJ; Tan SH; Sanda T
Haematologica; 2023 Feb; 108(2):367-381. PubMed ID: 36073513
[TBL] [Abstract][Full Text] [Related]
58. The 5' boundary of the human apolipoprotein B chromatin domain in intestinal cells.
Antes TJ; Namciu SJ; Fournier RE; Levy-Wilson B
Biochemistry; 2001 Jun; 40(23):6731-42. PubMed ID: 11389587
[TBL] [Abstract][Full Text] [Related]
59. Genomic Marks Associated with Chromatin Compartments in the CTCF, RNAPII Loop and Genomic Windows.
Szczepińska T; Mollah AF; Plewczynski D
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769020
[TBL] [Abstract][Full Text] [Related]
60. S1P-S1PR3-RAS promotes the progression of S1PR3
Zhu D; Jiang T; Ma D; Zhang H; Zhang J; Lv W; Gong M; Wang H; Liu Z; Su H; Zeng L; Liu S; Tang S; Yang B; Tshavuka FI; Fu G; Liu Z; Peng D; Liu H; Yan Z; Cao Z; Zhao H; He TC; Yu J; Shu Y; Zou L
Leukemia; 2023 Oct; 37(10):1982-1993. PubMed ID: 37591940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
